
Get to know BIO
Bio Protocol (BIO) is a Decentralized Science (DeSCI) platform.
Using blockchain to support the funding, development, and sharing of bioscience innovations
It focuses on the creation of BioDAOs for specialized research, such as gene editing or cancer research.
Bio Protocol runs primarily on Ethereum as an EVM-compatible native blockchain.
Enables the smooth use of smart contracts for the governance and funding of BioDAOS
Bio Protocol's Consensus Protocol relies on Ethereum's Proof-of-Stake (PoS) as it is a protocol built on Ethereum
Bio Protocol was founded in early 2025 by a team led by Paul Kohlhaas (tokenomics expert),
James Sinka (Research and Community), Jose Pinto (Legal Counsel), Leonard Boltz and Clemens Ortlepp (Product),
Including Nate Hindman (Growth Side)
Bio Protocol (BIO) has a primary Objective: to accelerate biotech research through decentralized funding and IP joint ownership.
By solving the high cost and limited access problems in the original Use case system, including the creation of BioDAOS for specific research.
Such as prolongation of life or rare diseases, IP tokens for fractional investment, and rewards to participants in clinical trials.
It supports global collaboration through curation and liquidity pools
The total supply of BIO is 3.32 billion BIO.
https://www.coingecko.com/learn/what-is-bio-protocol-crypto-desci
https://www.forbes.com/digital-assets/assets/bio-protocol-bio/
Cryptocurrency Knowledge
Securely register with a digital asset trading platform regulated by Thailand’s SEC.


